Home Markets Roche shutters most trials of Alzheimer’s drug after failed trials Roche shutters most trials of Alzheimer’s drug after failed trials Andrew M Dec 01, 2022 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/roche-shutters-most-trials-of-alzheimers-drug-after-failed-trials-2954930 Market Updates Pharmaceuticals (NEC) Window shutter www.investing.com/news/stock-market-news/roche-shutters-most-trials-of-alzheimers-drug-after-failed-trials-2954930